Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UC-MSCs for COVID-19 ARDS
NCT04355728Phase 2Completed
- Start
- Apr 2020
- Primary completion
- Oct 2020
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord mesenchymal stem cells in coronavirus disease 2019 (COVID-19), acute respiratory distress syndrome (ARDS). Started Apr 2020; status: completed.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
coronavirus disease 2019 (COVID-19)acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT04355728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04355728.